MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2017-10-20 / Biochem. Biophys. Res. Commun. 2017 12;494(1-2):13-19Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2017-10-19 / Eur Urol Focus 2018 04;4(3):442-454Dendritic cell therapy in melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-10-01 / Ann Transl Med 2017 Oct;5(19):386Dendritic cells based immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications, Pancreatic Cancer /von 2017-10-01 / Am J Cancer Res 2017;7(10):2091-2102Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma
/in Dendritic Cells, Exosome, Glioblastoma, International Publications /von 2017-09-23 / Cancer Lett. 2017 12;411:182-190Increased cycles of DC/CIK immunotherapy decreases frequency of Tregs in patients with resected NSCLC
/in Dendritic Cells, International Publications, NSCLC /von 2017-09-21 / Int. Immunopharmacol. 2017 Nov;52:197-202Hematologic neoplasms: Dendritic cells vaccines in motion
/in Dendritic Cells, International Publications /von 2017-09-12 / Clin. Immunol. 2017 10;183:181-190Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate Cancer /von 2017-09-01 / G Chir 2017 Sep-Oct;37(5):225-235Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2017-08-22 / Blood 2017 10;130(15):1713-1721
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de